Workflow
RHHBY to Advance Parkinson's Disease Drug to Late-Stage Development
ZACKS· 2025-06-16 14:50
Key Takeaways Roche will move prasinezumab into phase III for early-stage Parkinson's disease based on phase II data. Prasinezumab showed clinical trends and biomarker effects despite missing its phase II primary endpoint. RHHBY holds exclusive rights and will pay royalties to Prothena under a 2013 licensing agreement. Roche (RHHBY) announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease.Roche has a licensing agreement with Prothena (PR ...
Here's Why Zoetis (ZTS) is a Strong Momentum Stock
ZACKS· 2025-06-16 14:50
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? Dev ...
Here's Why Comstock Resources (CRK) is a Strong Momentum Stock
ZACKS· 2025-06-16 14:50
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...
Why Freeport-McMoRan (FCX) is a Top Momentum Stock for the Long-Term
ZACKS· 2025-06-16 14:50
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alongsi ...
Is CoreWeave Stock Expensive After A Whopping 4x Rise?
Forbes· 2025-06-16 14:50
CANADA - 2025/05/23: In this photo illustration, the CoreWeave (Core Weave) logo is seen displayed ... More on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesYou’ve likely seen some extreme fluctuations in the stock markets recently. However, few have been as striking as CoreWeave’s (NASDAQ: CRWV) path since its IPO in late March. The cloud computing company’s stock has dramatically surged, soaring from $40 to $147 – ...
Roku shares pop after striking major ad deal with Amazon
Proactiveinvestors NA· 2025-06-16 14:46
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Affirm Competitor Profile Report 2025: Explore Affirm's Journey As a Leading Buy Now, Pay Later Pioneer with 21M Users and 337K Merchant Partners
GlobeNewswire News Room· 2025-06-16 14:46
Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Competitor Profile: Affirm 2025" company profile has been added to ResearchAndMarkets.com's offering. With 21 million users and 337,000 merchant partners, the company offers both online and in-store payments and has become a strong alternative to credit cards, as well as a key payment solution for people with limited access to traditional credit. The report offers detailed information and insights into Affirm, including an in-depth look at its business operati ...
JD: 15% Growth Meets 8 Times Earnings
Seeking Alpha· 2025-06-16 14:45
In my last article about JD.com, Inc. (NASDAQ: JD ) – published in March 2025 – I once again made it clear that I am bullish about several Chinese technology companies and especially that JD.com is one of the best bargains in the ChineseMy analysis is focused on high-quality companies, that can outperform the market over the long-run due to a competitive advantage (economic moat) and high levels of defensibility. Focused on European and North American companies, but without constraints regarding market capi ...
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
ZACKS· 2025-06-16 14:45
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongsid ...
Here's Why AbbVie (ABBV) is a Strong Value Stock
ZACKS· 2025-06-16 14:45
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores. ...